Salim Mezaache
Marseille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Health risks associated with non-medical use of ketamine in France: National surveillance insights from the French Addictovigilance Network, 2019-2023.
Journal: Journal of psychopharmacology (Oxford, England)
Published: February 23, 2026
Emerging new psychoactive ketamine analogues: patterns of use and health risks identified by the French Addictovigilance Network.
Journal: The International journal on drug policy
Published: January 22, 2026
Home Cultivation of Cannabis in a Context of Prohibition: Results from Two Online Cross-Sectional Surveys of People Using Cannabis Daily in France.
Journal: International journal of environmental research and public health
Published: May 12, 2025
Prevention of opioid misuse and overdose risk and distribution of naloxone: Current practices, needs and prospects among dispensing pharmacists
Journal: Therapie
Published: October 04, 2024
Willingness to use a drug checking service for cannabis and cannabis-based products: results from an online survey of people who regularly use cannabis in France.
Journal: Harm reduction journal
Published: July 25, 2024
Exclusive Therapeutic Use of Cannabis in a Large Sample of Daily Cannabis Users in France: A Cross-Sectional Survey.
Journal: Journal of psychoactive drugs
Published: June 14, 2023
Opioid overdose prevention and naloxone diffusion (POP program): Results of an overview conducted among addiction specialized centres
Journal: Therapie
Published: December 07, 2022
Transmucosal fentanyl-related opioid use disorder in a cancer survivor.
Journal: Therapie
Published: November 25, 2022
A syndemic examination of injecting drug use, incarceration and multiple drug-related harms in French opioid users.
Journal: International journal of prisoner health
Published: December 20, 2021
Changes in cannabis use and associated correlates during France's first COVID-19 lockdown in daily cannabis users: results from a large community-based online survey.
Journal: Harm reduction journal
Published: October 08, 2021
Safety concerns on the abuse potential of esketamine: Multidimensional analysis of a new anti-depressive drug on the market.
Journal: Fundamental & clinical pharmacology
Published: July 05, 2021
Antidepressants abuse in subjects with opioid use disorders: A 10-year study in the French OPPIDUM program.
Journal: Fundamental & clinical pharmacology
Published: June 09, 2021
Last Updated: 09/26/2026